zintick

iRhythm IRTC

iRhythm Holdings, Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus

$90.22-30.70%close on Nov. 6, 2026 · volume 5.7M · Yahoo Finance

Price, last 54 sessions

$100.00$120.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 6, 2026 · high $134.00 · low $90.22 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Sept. 2, 2026Daniel G. Wilson
Chief Financial Officer
Sold773$121.83$94,175
Aug. 10, 2026Quentin S. Blackford
President and CEO, director
Sold26,859$124.65$3.35 million
Aug. 10, 2026Patrick Michael Murphy
CBO and CLO
Sold7,093$124.65$884,156
Aug. 10, 2026Chad Patterson
CHIEF COMM & PRODUCT OFFICER
Sold7,093$124.65$884,170
Aug. 10, 2026Sumi Shrishrimal
EVP, Chief Risk Officer
Sold5,372$124.65$669,641
Aug. 10, 2026Minang Turakhia
CHIEF MED/SCI OFCR EVP ADVTECH
Sold7,093$124.65$884,151
Aug. 3, 2026Mervin Smith
EVP Strategic Business Ops
Sold617$122.12$75,349
Aug. 3, 2026Julianne Rodda
EVP, CHIEF PEOPLE OFFICER
Sold2,112$122.12$257,919
Aug. 3, 2026Chad Patterson
CHIEF COMM & PRODUCT OFFICER
Sold2,712$122.12$331,192

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 20 →
  • 10-QNov. 5, 2026, 5:20 p.m. ETView on SEC.gov
  • 8-KNov. 5, 2026, 4:15 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewediRhythm Holdings Q3 2026 adjusted EPS of $0.82 beats $0.05 consensus on $221.6 million revenue, in line; FY2026 revenue guidance raised to $890 million-$895 million

  • SCHEDULE 13G/AOct. 13, 2026, 6:02 p.m. ETView on SEC.gov
  • 8-KOct. 5, 2026, 9:07 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewediRhythm Completes $237.5 Million Cash Acquisition of VitalConnect, Expanding Cardiac Monitoring Portfolio

  • 8-KSept. 22, 2026, 5 p.m. ETView on SEC.gov

    Regulation FD disclosure

  • 4Sept. 3, 2026, 4:01 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 8 a.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 4:15 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers